Explore News By Topic
07/07/2020
The Prostate Cancer Foundation Collaboration with Pan-Cancer Consortium Clarifies and Promotes Consistent Use of Common Terms for Biomarker and Germline Genetic Testing
LOS ANGELES, Calif., July 7, 2020 — The Prostate Cancer Foundation (PCF) has collaborated with a consortium of 41 leading patient advocacy organizations, professional societies and industry partners to publish a white paper detailing recommendations for the use of testing terminology in precision medicine for patient education throughout the cancer... Read More
03/25/2020
The Second Annual PCF Black History Month Assist Challenge sets new Fundraising Record by raising more than $500,000 for Prostate Cancer Research
LOS ANGELES, Calif., March 25, 2020 – In its sophomore year, the Second Annual Prostate Cancer Foundation Black History Month Assist Challenge more than tripled its fundraising efforts, compared to 2019, by raising more than $500,000 to combat prostate cancer, a disease that affects more than three million men in... Read More
03/18/2020
Kristen Bell Selects the Winners of the Prostate Cancer Foundation’s 3rd Annual True Love Contest
LOS ANGELES, Calif., March 18, 2020 – The Prostate Cancer Foundation (PCF) and actress Kristen Bell announced today, the winners of the 3rd Annual TRUE Love Contest that honors caregivers and supporters of prostate cancer patients. From more than a hundred inspirational stories, Bell chose two heartfelt stories – one... Read More
02/13/2020
Cleveland Clinic Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer
February 13, 2020, CLEVELAND: In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that the a testosterone-related genetic variant – HSD3B1(1245C) – is associated with more aggressive disease and shorter survival in men with metastatic prostate cancer. This study – the first clinical trial validation of the... Read More
02/04/2020
The Prostate Cancer Foundation Recruits NBA and NHL Teams to Join Forces for the 2nd Annual PCF Black History Month Assist Challenge
LOS ANGELES, Calif., February 4, 2020 – The Prostate Cancer Foundation (PCF) has drafted teams from the NBA and NHL to help fight prostate cancer with the 2nd Annual PCF Black History Month Assist Challenge. Teams participating during February include Atlanta Hawks, Brooklyn Nets, Chicago Bulls, Detroit Pistons, Indiana Pacers,... Read More
01/29/2020
The Prostate Cancer Foundation and Kristen Bell Honor Caregivers with its 3rd Annual True Love Contest
LOS ANGELES, Calif., January 29, 2020 – Beginning February 1st, the Prostate Cancer Foundation (PCF) will launch its 3rd Annual TRUE Love contest to honor family and caregivers for their diligent work in caring for their loved ones living with prostate cancer. TRUE pays tribute to the unsung heroes –... Read More
11/11/2019
The Prostate Cancer Foundation Adds Four New Centers Of Excellence To Serve And Honor Veterans With Prostate Cancer
LOS ANGELES, Calif., Nov. 11, 2019 /PRNewswire/ -- Four new Prostate Cancer Foundation (PCF) Centers of Excellence (COEs) have joined the PCF's dedicated network of centers executing the ambitious mission of improving the care for U.S. Veterans with prostate cancer. With the addition of the new centers, the PCF has established 10 COEs... Read More
09/26/2019
THE PROSTATE CANCER FOUNDATION ANNOUNCES A COLLABORATIVE GRANTS PROGRAM IN PROSTATE CANCER RESEARCH
LOS ANGELES, Calif., September 26, 2019 – The Prostate Cancer Foundation (PCF) today announced a collaboration with Pfizer Global Medical Grants to fund approximately $2 million in research grants through a Competitive Research Grants Program, which is focused on investigating talazoparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in prostate cancer.... Read More
09/04/2019
The Prostate Cancer Foundation Made History by Lighting U.S. Landmarks “Blue” Across All 50 States to Illuminate Prostate Cancer Issue
LOS ANGELES, Calif., September 4, 2019 – For the first time in American history, U.S. landmarks in all 50 states (and the District of Columbia) were lit blue on September 3 to kick-off Prostate Cancer Awareness Month. The Prostate Cancer Foundation’s (PCF) “Light It Blue” campaign is a national effort... Read More
07/30/2019
FDA Approves Bayer’s Nubeqa® (darolutamide), a New Treatment for Men with Non-Metastatic Castration-Resistant Prostate Cancer
WHIPPANY, N.J., July 30, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today approved Nubeqa® (darolutamide), an androgen receptor inhibitor (ARi), for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC). The FDA approval is based on the Phase III ARAMIS trial evaluating Nubeqa plus androgen deprivation... Read More